SCHEMBL6279707

SCHEMBL6279707

NC(=O)c1cnc2cccnn2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.43
MAP2K1 Q02750 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
KDM4E B2RXH2 2/20 0.39
PARP1 P09874 1/20 0.38
KLK7 P49862 1/20 0.37
FYN P06241 3/20 0.37
SSTR4 P31391 1/20 0.37
HSD11B1 P28845 1/20 0.37
DYRK1A Q13627 1/20 0.37
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
PDE4B Q07343 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RIPK2 O43353 1/20 0.36
TLR8 Q9NR97 1/20 0.35
F7 P08709 1/20 0.35
F3 P13726 1/20 0.35
SARM1 Q6SZW1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454803 0.80 TGFBR1 (0.48) MKNK1KLK7FYNSSTR4HSD11B1
SCHEMBL11457347 0.77 KDM4E (0.57) KDM4EL3MBTL1ALDH1A1
SCHEMBL31314234 0.73 MKNK1 (0.47) MKNK1KLK7SSTR4HSD11B1DYRK1A
SCHEMBL1691581 0.73 MKNK1 (0.47) MKNK1KLK7FYNSSTR4HSD11B1
SCHEMBL20556228 0.73 CYP1A2 (0.42) MAP2K1CLK4DYRK1BKDM4EPDE4B
SCHEMBL6347546 0.73 ALDH1A1 (0.58) KDM4EALDH1A1
SCHEMBL2263775 0.72 MKNK1 (0.43) MKNK1KLK7FYNSSTR4HSD11B1
SCHEMBL2862103 0.71 MKNK1 (0.49) MKNK1KDM4EKLK7FYNSSTR4
SCHEMBL29893844 0.71 MKNK1 (0.49) MKNK1DYRK1BKLK7SSTR4HSD11B1
SCHEMBL30100800 0.70 MKNK1 (0.47) MKNK1DYRK1BKLK7FYNSSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903097-B2 Heterocycle carboxamides as antiviral agents PHARMACIA & UPJOHN COMPANY (US) 2005-06-07 US disclosed
US-20040142928-A1 Heterocycle carboxamides as antiviral agents BUNDY GORDON L (US) 2004-07-22 US disclosed
US-20030207880-A1 Heterocycle carboxamides as antiviral agents BUNDY GORDON L (US) 2003-11-06 US disclosed
US-6559145-B2 Herpes virus PHARMACIA & UPJOHN COMPANY 2003-05-06 US disclosed
EP-1301493-A2 HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-04-16 EP disclosed
US-20020025960-A1 Heterocycle carboxamides as antiviral agents PHARMACIA & UPJOHN COMPANY 2002-02-28 US disclosed
WO-2002004444-A2 HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142928-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 MKNK1 2020/4885MAP2K1 4177/4885CLK4 4385/4885
US-20020025960-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 MKNK1 2020/4885MAP2K1 4177/4885CLK4 4385/4885
US-20030207880-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 MKNK1 2020/4885MAP2K1 4177/4885CLK4 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.